Advisor Partners Ii, LLC Neogenomics Inc Transaction History
Advisor Partners Ii, LLC
- $2.47 Billion
- Q3 2023
A detailed history of Advisor Partners Ii, LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Advisor Partners Ii, LLC holds 31,918 shares of NEO stock, worth $442,702. This represents 0.02% of its overall portfolio holdings.
Number of Shares
31,918
Previous 32,347
1.33%
Holding current value
$442,702
Previous $519,000
24.47%
% of portfolio
0.02%
Previous 0.02%
Shares
4 transactions
Others Institutions Holding NEO
# of Institutions
280Shares Held
128MCall Options Held
1.13MPut Options Held
232K-
Black Rock Inc. New York, NY19.9MShares$275 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.2MShares$197 Million0.0% of portfolio
-
Brown Advisory Inc9.67MShares$134 Million0.21% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.86MShares$95.1 Million0.07% of portfolio
-
Janus Henderson Group PLC London, X06.28MShares$87.1 Million0.06% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.74B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...